TipRanks
Go Ultimate55% OFF

Emcure Pharmaceuticals Limited (EMCURE) Financial Statements

Emcure Pharmaceuticals Limited Financial Overview

Emcure Pharmaceuticals Limited's market cap is currently $354.40B. The company's EPS TTM is $10.04; its P/E ratio is 35.09; and it has a dividend yield of 0.19%. Emcure Pharmaceuticals Limited is estimated to report earnings on November 3, 2026, and the estimated EPS forecast is $14.90. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Mar 25Mar 25
Income Statement
Total Revenue$ 78.08B$ 92.04B
Gross Profit$ 275.05M$ 35.79B
Operating Income$ 10.85B$ 13.74B
EBITDA$ 14.95B$ 18.46B
Net Income$ 6.81B$ 9.24B
Balance Sheet
Cash & Short-Term Investments$ 1.98B$ 2.16B
Total Assets$ 82.33B$ 96.12B
Total Debt$ 10.23B$ 15.21B
Net Debt$ 9.01B$ 13.85B
Total Liabilities$ 35.91B$ 46.36B
Stockholders' Equity$ 44.46B$ 49.50B
Cash Flow
Free Cash Flow$ 4.45B$ 4.90B
Operating Cash Flow$ 8.52B$ 8.51B
Investing Cash Flow$ -940.01M$ -11.95B
Financing Cash Flow$ -8.14B$ 4.38B

Currency in INR

Emcure Pharmaceuticals Limited Earnings and Revenue History

040B80B120B8.4 %9 %9.6 %10.2 %EarningsProfit Margin20242025RevenueEarningsProfit Margin

Emcure Pharmaceuticals Limited Debt to Assets

040B80B120B42.5 %45 %47.5 %50 %LiabilitiesDebt to Assets20242025AssetsLiabilitiesDebt to Assets

Emcure Pharmaceuticals Limited Cash Flow

-15B-10B-5B05B10B20242025OperatingInvestingFinancing

Emcure Pharmaceuticals Limited Forecast EPS vs Actual EPS

81012141618Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27EPS EstimateBeatMiss